CXJ-2
CXJ-2 is a cyclic peptide, and exhibits moderate affinity toward elastin derived peptides (EDPs). CXJ-2 exhibits potent activities to inhibit the PI3K/ERK pathway and decrease hepatic stellate cell proliferation and migration. CXJ-2 possesses potent antifibrotic efficacy.
For research use only. We do not sell to patients.
- CAS No.: 2919976-92-2
- Formula: C55H87N15O22
- Molecular Weight:1310.37
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
|
PI3K |
ERK |
CXJ-2 (0.1 mg/kg, SC, single dose) shows favorable pharmacokinetic properties[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male C57BL/6J mice (6-8 weeks, 20-24 g, CCl4-induced liver fibrosis model)[1]
-
Dosage:150 μg/kg
-
Administration:IP, daily, for 3 weeks
-
Result:Significantly decreased the HYP (hydroxyproline) content in liver tissue. Decreased collagen deposition. Remarkably diminished hepatic fibrosis.
-
Animal Model:Sprague-Dawley rats[1]
-
Dosage:0.1 mg/kg
-
Administration:SC, single dose (Pharmacokinetic Analysis)
-
Result:Showed favorable pharmacokinetic properties (Tmax=0.33 h, T1/2=0.46 h), and displayed enhanced clearance profiles. Displayed significantly higher serum stability with a half-life longer than 36 h.
Chemical Information
-
CAS No. 2919976-92-2
-
Molecular Weight 1310.37
-
Formula C55H87N15O22
-
Sequence
cyclo(Val-{Iva}-Gly-Ser-Pro-Ser-Ala-Gln-Glu-Glu-Ala-Ser-Pro-Ala)
-
Sequence Shortening
cyclo(V-{Iva}-GSPSAQEEASPA)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Powered by Bioz